Business Description
NexgenRx Inc
NAICS : 621499
SIC : 8699
ISIN : CA65337X1042
Description
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 12.79 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 157.3 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.49 | |||||
Beneish M-Score | 0.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.6 | |||||
3-Year EBITDA Growth Rate | 23.1 | |||||
3-Year FCF Growth Rate | 95.7 | |||||
3-Year Book Growth Rate | -6.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.9 | |||||
9-Day RSI | 63.49 | |||||
14-Day RSI | 62.5 | |||||
6-1 Month Momentum % | 16.07 | |||||
12-1 Month Momentum % | 62.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.1 | |||||
Days Sales Outstanding | 26.08 | |||||
Days Payable | 140.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.41 | |||||
Dividend Payout Ratio | 0.5 | |||||
3-Year Dividend Growth Rate | 14.5 | |||||
Forward Dividend Yield % | 3.18 | |||||
5-Year Yield-on-Cost % | 2.41 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 2.77 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 85.54 | |||||
Operating Margin % | 18.85 | |||||
Net Margin % | 13.7 | |||||
EBITDA Margin % | 22.6 | |||||
FCF Margin % | 15.89 | |||||
OCF Margin % | 17.05 | |||||
ROE % | 31.16 | |||||
ROA % | 6.63 | |||||
ROIC % | 8.24 | |||||
ROC (Joel Greenblatt) % | 203.85 | |||||
ROCE % | 37.63 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.68 | |||||
PE Ratio without NRI | 18.86 | |||||
Shiller PE Ratio | 45.26 | |||||
Price-to-Owner-Earnings | 18.56 | |||||
PS Ratio | 2.4 | |||||
PB Ratio | 5.03 | |||||
Price-to-Tangible-Book | 7.54 | |||||
Price-to-Free-Cash-Flow | 14.75 | |||||
Price-to-Operating-Cash-Flow | 14.03 | |||||
EV-to-EBIT | 11.94 | |||||
EV-to-EBITDA | 9.08 | |||||
EV-to-Revenue | 2.05 | |||||
EV-to-FCF | 12.91 | |||||
Price-to-GF-Value | 1.97 | |||||
Price-to-Projected-FCF | 1.89 | |||||
Price-to-Median-PS-Value | 1.33 | |||||
Price-to-Graham-Number | 2.38 | |||||
| Price-to-Net-Current-Asset-Value | 11.32 | |||||
Earnings Yield (Greenblatt) % | 8.38 | |||||
FCF Yield % | 7.44 | |||||
Forward Rate of Return (Yacktman) % | 6.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NEGXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NexgenRx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.86 | ||
| EPS (TTM) ($) | 0.023 | ||
| Beta | -0.0711 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 1.68 | ||
| Volatility % | 45.15 | ||
| 14-Day RSI | 62.5 | ||
| 14-Day ATR ($) | 0.043311 | ||
| 20-Day SMA ($) | 0.33405 | ||
| 12-1 Month Momentum % | 62.5 | ||
| 52-Week Range ($) | 0.041 - 0.48 | ||
| Shares Outstanding (Mil) | 71.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NexgenRx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NexgenRx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| CAD 0.005000 Cash Dividend | 2026-08-28 | 0.33 (+0.00%) | ||
| CAD 0.005000 Cash Dividend | 2026-04-24 | 0.27 (+0.00%) | ||
| CAD 0.005000 Cash Dividend | 2025-12-17 | 0.28 (+0.00%) | ||
| CAD 0.005000 Cash Dividend | 2025-08-25 | 0.20 (+0.00%) | ||
| CAD 0.005000 Cash Dividend | 2025-04-25 | 0.20 (+0.00%) | ||
| CAD 0.005000 Cash Dividend | 2024-12-16 | 0.20 (+0.00%) |
Show
Entries
NexgenRx Inc Frequently Asked Questions
What is NexgenRx Inc(NEGXF)'s stock price today?
The current price of NEGXF is $0.45. The 52 week high of NEGXF is $0.48 and 52 week low is $0.04.
When is next earnings date of NexgenRx Inc(NEGXF)?
The next earnings date of NexgenRx Inc(NEGXF) is .
Does NexgenRx Inc(NEGXF) pay dividends? If so, how much?
The Dividend Yield %  of NexgenRx Inc(NEGXF) is 2.41% (As of Today), Highest Dividend Payout Ratio of NexgenRx Inc(NEGXF) was 2. The lowest was 0.5. And the median was 1.5. The  Forward Dividend Yield % of NexgenRx Inc(NEGXF) is 3.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers